-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BIO Investor Forum
Technology Transfer Symposium in San Francisco
In the midst of turbulent economic times, and at a moment when the U.S. is looking to encourage technology job creation in the coming decade, an increasing number of public and private sector initiatives have been proposed to spur job creation. While the U.S. leads in the area of biotechnology, there is no guarantee that this competitive edge will continue. Moreover, although the U.S. is more prolific in life science discoveries than any other single country in the Read More >
BIO Investor Forum Company Snapshot: Syndax Pharmaceuticals
Next up in our Company Snapshot segment for the BIO Investor Forum is another presenting company of the event. Hear from Joanna Horobin, President & CEO of Syndax Pharmaceuticals, Inc. Company Snapshot What are the short-term and long-term priorities for your company? Near-term we are focused on moving our lead product candidate, entinostat, in to a phase 3 clinical trial for post-menopausal women with estrogen receptor-positive (ER+) metastatic breast cancer (MBC). Long-term our goal is Read More >
BIO Investor Forum Company Snapshot: GlobeImmune, Inc.
The BIO Investor Forum will be here before we know it, and we wanted to take the opportunity to highlight some of the companies who will be presenting at the 10th anniversary event. In our first Company Snapshot, hear from Timothy C. Rodell, the President and Chief Executive Officer of GlobeImmune, Inc. Company Snapshot Q: What are the short-term and long-term priorities for your company? Short term – in oncology, completing the GI-4000 phase Read More >
Fall Preview: Business Development Events
Now that the Business Forum and International Convention are behind us, our Business Development department has been gearing up for a very busy Fall schedule. The Line-Up For our first Fall event, BIO returns to India for its 2nd annual BIO India International Partnering Conference September 21st and 22nd. Last year’s conference attracted more than 400 attendees representing 220 companies, from 17 countries around the world, – who scheduled over 750 meetings. We’ve had Read More >
State of the Industry – From BIO Investor Forum 2010
Here is our slide deck from the 9th annual BIO Investor Forum in San Francisco: BIO Investor Forum 2010 final From the media and blogosphere: Bloomberg in vivo blog Medical Technology Stock Letter
